Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PB1023 in Adults With Type 2 Diabetes Mellitus
NCT01236404Phase 2Completed
- Sponsor
- PhaseBio Pharmaceuticals
- Start
- Nov 2010
- Primary completion
- Nov 2011
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of froniglutide in type 2 diabetes mellitus (T2DM), sponsored by PhaseBio Pharmaceuticals. Started Nov 2010; status: completed.
02
Drugs
froniglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01236404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01236404.